Loading...

EVERESTO Everest Organics Ltd Expansion Plans Announcement

vrst

VRST

Everest Organics Ltd

(EVERESTO)

2025 Announcement

Show Summary

Show Summary

Annual Compliance Report

Financial Results Released

Auditor Appointment

Regulatory Compliance

Office Relocation

Trading Approval Received

BSE Listing Approval

Financial Results Published

Compliance Certificate

Postal Ballot Notice

Capital Structure Update

Management Change

Management Change

Warrant and Share Allotment

Equity Shares Issuance

EGM Announcement

Preferential Issue Announce...

Preferential Issue

Board Meeting Update

Board Meeting Cancelled

Director Resignation

Director Resignation

Director Resignation

Director Resignation

Financial Results Released

Management Appointment

Director Appointment

Regulatory Compliance

Director Retirement

Directors Demise

AGM Notice Published

AGM Announcement

Compliance Certificate Subm...

Appointment of Management C...

Resignation Announcement

Compliance Report Submission

Financial Results Publication

USFDA Inspection

Compliance Certificate

Compliance Certificate

Compliance Certificate Subm...

Compliance Certificate

Financial Results Publication

Resignation Letter

Resignation of Company Secr...

Certificate under Regulatio...

Management Appointment

30th Annual General Meeting...

Credit Rating Update

Financial Statements

Management Changes

Submission of Compliance Re...

Publication of Q4 Results

External Links:

Data:

Everest Organics Ltd. has received Korea Drug Master File (KDMF) approval for its Rabeprazole Sodium API, allowing exports to South Korea.

AI Assistant

Everest Organics Ltd

2025

Announcement

Find Answers

Ask about any part of the document to get insights, explanations, or key details.